2011
DOI: 10.1254/jphs.11r01cr
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine

Abstract: Abstract. Several lines of evidence suggest that cholinergic deficits may contribute to the pathophysiology of psychiatric disorders as well as Alzheimer's disease. There is growing clinical evidence that galantamine, currently used for the treatment of Alzheimer's disease, may improve cognitive dysfunction and psychiatric illness in schizophrenia, major depression, bipolar disorder, and alcohol abuse. Since galantamine is a rather weak acetylcholinesterase inhibitor, but has additional allosteric potentiating… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
50
0
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 96 publications
(57 citation statements)
references
References 99 publications
3
50
0
1
Order By: Relevance
“…On the other hand, memantine administration results in significant increases in extracellular dopamine, noradrenaline, and their metabolites in the cortical regions and in dopamine reduction in rat hippocampus (17). The influence of galantamine and memantine on the release of dopamine and noradrenaline may contribute to the beneficial effects of their co-administration on the non-cognitive symptoms of dementia that are usually correlated to these neurotransmitters (16).…”
mentioning
confidence: 98%
“…On the other hand, memantine administration results in significant increases in extracellular dopamine, noradrenaline, and their metabolites in the cortical regions and in dopamine reduction in rat hippocampus (17). The influence of galantamine and memantine on the release of dopamine and noradrenaline may contribute to the beneficial effects of their co-administration on the non-cognitive symptoms of dementia that are usually correlated to these neurotransmitters (16).…”
mentioning
confidence: 98%
“…Acoustic startle responses were measured in a startle chamber (SR-LAB ® ; San Diego Instruments, San Diego, CA, USA) as described previously (8). After a background noise of 65 dB had been presented for a 5-min acclimation period, each mouse was exposed to four consecutive blocks with a total of 100 trials over the approximately 30-min test session.…”
mentioning
confidence: 99%
“…20,21 One of the most widely used anti-cholinesterase drug galantamine is derived from plant sources. 22 Nicotinic and muscarinic receptor-modulating properties of galantamine contribute to the antipsychotic effect and development of cognitive dysfunction. Available drugs which are used to treat Alzheimer's disease are mainly the inhibitors of cholinesterase enzymes.…”
Section: Butyrylcholinesterase (Bche) Inhibitory Activitymentioning
confidence: 99%